Edition:
India

MannKind Corp (MNKD.OQ)

MNKD.OQ on NASDAQ Stock Exchange Global Market

2.13USD
22 Mar 2019
Change (% chg)

$-0.07 (-3.18%)
Prev Close
$2.20
Open
$2.19
Day's High
$2.23
Day's Low
$2.08
Volume
689,007
Avg. Vol
539,268
52-wk High
$3.04
52-wk Low
$0.94

Latest Key Developments (Source: Significant Developments)

Mannkind Q4 Loss Per Share $0.06
Tuesday, 26 Feb 2019 

Feb 26 (Reuters) - MannKind Corp ::Q4 LOSS PER SHARE $0.06.Q4 EARNINGS PER SHARE ESTIMATE $0.22 -- REFINITIV IBES DATA.QTRLY TOTAL REVENUES WERE $16.0 MILLION; 254% GROWTH VERSUS. Q4 2017.ENDED 2018 WITH $71.7 MILLION IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH.  Full Article

Mannkind Announces Pricing Of $40 Million Public Offering
Thursday, 20 Dec 2018 

Dec 20 (Reuters) - MannKind Corp ::MANNKIND ANNOUNCES PRICING OF $40 MILLION PUBLIC OFFERING.PRICING OF UNDERWRITTEN PUBLIC OFFERING OF 26.7 MILLION SHARES OF ITS STOCK AND WARRANTS.EACH SHARE OF COMMON STOCK IS BEING SOLD TOGETHER WITH A WARRANT TO PURCHASE ONE SHARE OF COMMON STOCK FOR COMBINED PURCHASE PRICE OF $1.50.  Full Article

MannKind Announces Commencement Of Public Offering
Thursday, 20 Dec 2018 

Dec 19 (Reuters) - MannKind Corp ::MANNKIND ANNOUNCES COMMENCEMENT OF PUBLIC OFFERING.MANNKIND - COMMENCED AN UNDERWRITTEN PUBLIC OFFERING TO ISSUE AND SELL SHARES OF COMMON STOCK AND WARRANTS TO PURCHASE SHARES OF ITS COMMON STOCK.  Full Article

MannKind Corp Reports Q3 Loss Per Share $0.16
Thursday, 1 Nov 2018 

Nov 1 (Reuters) - MannKind Corp ::MANNKIND CORPORATION REPORTS 2018 THIRD QUARTER FINANCIAL RESULTS.Q3 LOSS PER SHARE $0.16.FOR Q3 OF 2018, AFREZZA NET REVENUE WAS $4.4 MILLION, AN INCREASE OF 121%.  Full Article

Mannkind Corp - CO, UNIT Entered Into Tenth Amendment To Facility Agreement Dated July 1, 2013
Thursday, 27 Sep 2018 

Sept 27 (Reuters) - MannKind Corp ::MANNKIND CORP - ON SEPT 26, CO, UNIT ENTERED INTO TENTH AMENDMENT TO FACILITY AGREEMENT DATED JULY 1, 2013 - SEC FILING.  Full Article

United Therapeutics And Mannkind Announce Collaboration For Pulmonary Hypertension Products
Tuesday, 4 Sep 2018 

Sept 4 (Reuters) - MannKind Corp ::UNITED THERAPEUTICS AND MANNKIND ANNOUNCE COLLABORATION FOR PULMONARY HYPERTENSION PRODUCTS.MANNKIND CORP - MANNKIND CORPORATION WILL RECEIVE AN UPFRONT PAYMENT OF $45 MILLION.MANNKIND CORP - MANNKIND WILL ALSO RECEIVE POTENTIAL MILESTONE PAYMENTS OF UP TO $50 MILLION.MANNKIND CORP - WILL BE ENTITLED TO RECEIVE LOW DOUBLE-DIGIT ROYALTIES ON NET SALES OF PRODUCT.MANNKIND - GRANTED UNITED THERAPEUTICS AN OPTION TO EXPAND LICENSE TO INCLUDE OTHER ACTIVE INGREDIENTS FOR TREATMENT OF PULMONARY HYPERTENSION.  Full Article

United Therapeutics And Mannkind Announce Collaboration For Pulmonary Hypertension Products
Tuesday, 4 Sep 2018 

Sept 4 (Reuters) - MannKind Corp ::UNITED THERAPEUTICS AND MANNKIND ANNOUNCE COLLABORATION FOR PULMONARY HYPERTENSION PRODUCTS.UNITED THERAPEUTICS CORP - EXCLUSIVE LICENSE AGREEMENT FOR TREPROSTINIL TECHNOSPHERE.UNITED THERAPEUTICS CORP - $95 MILLION IN UPFRONT AND MILESTONE PAYMENTS UNDER DEAL.UNITED THERAPEUTICS CORP - RESEARCH AGREEMENT FOR ADDITIONAL PRODUCTS FOR ADDITIONAL $10 MILLION.  Full Article

Tanner Pharma Group Signs Distribution Agreement With MannKind Corporation
Thursday, 2 Aug 2018 

Aug 2 (Reuters) - MannKind Corp ::TANNER PHARMA GROUP SIGNS DISTRIBUTION AGREEMENT WITH MANNKIND CORPORATION.TANNER PHARMA GROUP - AGREEMENT NAMES CO AS DISTRIBUTOR OF AFREZZA INHALATION POWDER IN AREAS OUTSIDE OF U.S. WHERE PRODUCT IS NOT YET REGISTERED.  Full Article

Mannkind And Tanner Pharma Enter Into An Ex-U.S. Distribution Agreement For Afrezza®
Friday, 27 Jul 2018 

July 27 (Reuters) - MannKind Corp ::MANNKIND AND TANNER PHARMA GROUP ENTER INTO AN EX-U.S. DISTRIBUTION AGREEMENT FOR AFREZZA®.MANNKIND CORP - AGREEMENT NAMES TANNER AS A DISTRIBUTOR OF AFREZZA OUTSIDE OF UNITED STATES IN REGIONS PRODUCT IS NOT YET REGISTERED.MANNKIND CORP - DISTRIBUTION WILL BE MANAGED BY TANNERGAP, INC UNIT OF TANNER PHARMA GROUP.  Full Article

Mannkind Corp To Issue 2.25 Mln Shares In Exchange For Cancellation Of $5.0 Mln Principal Amount Of 2021 Notes
Friday, 25 May 2018 

May 25 (Reuters) - MannKind Corp ::MANNKIND CORP - TO ISSUE 2.25 MILLION SHARES IN EXCHANGE FOR CANCELLATION OF $5.0 MILLION PRINCIPAL AMOUNT OF 2021 NOTES.MANNKIND CORP - ENTERED INTO A EXCHANGE AGREEMENT WITH CERTAIN HOLDERS OF ITS OUTSTANDING 5.75% CONVERTIBLE SENIOR NOTES DUE 2021 - SEC FILING.  Full Article